Bumetanide - Revision history

Danbot: Switch SMW query from broadtable to table format for better layout with TOC

2026-03-20T21:58:38Z

Switch SMW query from broadtable to table format for better layout with TOC

2026-03-20T17:26:47Z

Fix SMW query: replace link=subject with mainlabel=- to fix broken subobject fragment links

2026-03-20T16:45:05Z

Add dynamic SMW Indications by Condition table (auto-populated from disease pages via MedicationDose template)

← Older revision		Revision as of 16:45, 20 March 2026
Line 50:		Line 50:

	==Comments==		==Comments==


			==Indications by Condition==
			''The following table is automatically generated from disease/condition pages across WikEM.''

			{{#ask:[[Has DrugName::Bumetanide]]
			\|?Has Indication=Indication
			\|?Has Dose=Dose
			\|?Has Context=Context
			\|?Has Route=Route
			\|?Has Population=Population
			\|format=broadtable
			\|headers=plain
			\|link=subject
			\|sort=Has Indication
			\|limit=50
			}}

	==See Also==		==See Also==

2021-03-08T20:56:24Z

2017-10-11T23:15:10Z

Pharmacology: added metabolism

← Older revision		Revision as of 23:15, 11 October 2017
Line 43:		Line 43:
	*Rapid onset		*Rapid onset
	*Half-life: 1-6 hours		*Half-life: 1-6 hours
	*Metabolism:		*Metabolism: Partially metabolized in liver
	*Excretion: Mostly renal		*Excretion: Mostly renal

2017-10-11T23:13:45Z

edited dosage forms, strengths, trade names

← Older revision		Revision as of 23:13, 11 October 2017
Line 4:		Line 4:
	==Administration==		==Administration==
	*Type: Loop [[diuretic]]		*Type: Loop [[diuretic]]
	*Dosage Forms:		*Dosage Forms: injectable solution, tablet
			*Dosage Strengths: injectable solution: 0.25mg/mL; tablet: 0.5, 1, 2mg
	*Routes of Administration: IV, PO		*Routes of Administration: IV, PO
	*Common Trade Names: Bumex		*Common Trade Names: Bumex, Burinex

	==Adult Dosing==		==Adult Dosing==

2017-01-15T21:04:27Z

Adult Dosing

← Older revision		Revision as of 21:04, 15 January 2017
Line 9:		Line 9:

	==Adult Dosing==		==Adult Dosing==
	''40mg [[furosemide]] = 20mg [[torsemide]] = 1mg bumetanide''		''40mg [[furosemide]] = 20mg [[torsemide]] = 1mg bumetanide = 50 mg [[ethacrynic acid]]''
	*0.5 to 1 mg IV or 0.5-2mg PO. If inadequate response, repeat q2-3 hours to maximum of 10 mg per day		*0.5 to 1 mg IV or 0.5-2mg PO. If inadequate response, repeat q2-3 hours to maximum of 10 mg per day

	==Pediatric Dosing==		==Pediatric Dosing==

2016-12-22T16:34:13Z

← Older revision		Revision as of 16:34, 22 December 2016
Line 46:		Line 46:

	==Mechanism of Action==		==Mechanism of Action==
	*~~inhibits~~ the reabsorption of sodium and chloride in the ascending limb of the loop of Henle		*Inhibits the reabsorption of sodium and chloride in the ascending limb of the loop of Henle

	==Comments==		==Comments==

2016-12-22T16:30:17Z

← Older revision		Revision as of 16:30, 22 December 2016
Line 1:		Line 1:
			==General==
			*80-100% oral bioavailability as opposed to [[furosemide]]<ref>Asare K. Management of Loop Diuretic Resistance in the Intensive Care Unit. Am J Health Syst Pharm. 2009;66(18):1635-1640.</ref>

	==Administration==		==Administration==
	*Type: Loop [[diuretic]]		*Type: Loop [[diuretic]]

2016-10-27T16:05:47Z

Text replacement - "* " to "*"

← Older revision		Revision as of 16:05, 27 October 2016
Line 43:		Line 43:

	==Mechanism of Action==		==Mechanism of Action==
	* inhibits the reabsorption of sodium and chloride in the ascending limb of the loop of Henle		*inhibits the reabsorption of sodium and chloride in the ascending limb of the loop of Henle

	==Comments==		==Comments==